Cigna Group is expected to release its Q3 2026 10-Q filing on October 28, 2026, before market open. Last quarter: In Q2 FY2026, The Cigna Group delivered total revenue of $71.67B (+6.7% YoY) and net income of $1.66B (+8.4% YoY), driven by strong operating growth in Cigna Healthcare and expanding volume in Evernorth Health Services.
EPS Estimate
$7.87
Revenue Estimate
$74.4B
Analyst consensus from Finnhub. Actual results posted within minutes of the SEC filing on the CI page.
Drawn from management commentary in the Q2 2026 10-Q:
Cigna Healthcare pre-tax adjusted income increased 17% YoY to $1.28B for Q2 FY2026, driven by improved operating margins in the U.S. Employer business, while segment adjusted revenues rose 9% YoY to $11.73B due to higher premium rates in employer insured and stop loss products.
Evernorth Health Services generated adjusted revenues of $61.47B (+6% YoY) in Q2 FY2026, supported by changes in claims composition in Pharmacy Benefit Services and customer growth in Specialty and Care Services, despite client-focused strategic initiatives impacting pre-tax adjusted income ($1.66B, -2% YoY).
Total medical customers increased 2% YoY to 18.41 million as of June 30, 2026, driven by customer additions in Middle Market (+3%) and Select market (+1%) segments. Cigna Healthcare's Medical Care Ratio (MCR) increased 130 bps YoY to 84.5% primarily due to higher prior-year risk adjustment benefits recognized in Q2 FY2025.
Revenue
$71.67B
+6.68% YoY
EPS (Diluted)
$6.29
+10.16% YoY
Operating Income
$2.68B
+16.05% YoY
Add CI to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.